Brief: Ipsen FY 2024 Total Sales Growth Of 9.9% At Cer, 8.7% Reported
Feb 13 (Reuters) - Ipsen SA IPN.PA :
* FY 2024 TOTAL SALES GROWTH OF 9.9% AT CER, 8.7% REPORTED
* FY 2024 CORE OPERATING INCOME OF €1,109M, GROWING 10.8%
* FINANCIAL GUIDANCE: FOR 2025 INCLUDING TOTAL SALES GROWTH
GREATER THAN 5.0%3 AT CER
* FINANCIAL GUIDANCE FOR 2025: CORE OPERATING MARGIN GREATER
THAN
30.0% OF TOTAL SALES
Source text: ID:nGNE7K1qc
Further company coverage: IPN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Ipsen SA
See all newsHealth Rounds: New blood test matches gold standard for liver disease diagnosis
Brief: Ipsen Late-Breaking Data Raises Ambitions In PBC
Brief: Charles River Laboratories International Virtual Control Group To Be Used In Glp Study For Ipsen
Pharming shares rise after preliminary Q3 revenue beat
France's Ipsen Q3 sales rise 28% driven by core portfolio